SummaryGlobal Market Direct’s pharmaceuticals report, “Immune Pharmaceuticals Ltd -Product Pipeline Review - 2012” provides data on the Immune PharmaceuticalsLtd’s research and development focus. The report includes information oncurrent developmental pipeline, complete with latest updates, and features ondiscontinued and dormant projects.This report is built using data and information sourced from Global MarketsDirect’s proprietary databases, Immune Pharmaceuticals Ltd’s corporatewebsite, SEC filings, investor presentations and featured press releases, bothfrom Immune Pharmaceuticals Ltd and industry-specific third party sources,put together by Global Markets Direct’s team.
Scope- Immune Pharmaceuticals Ltd - Brief Immune Pharmaceuticals Ltd overviewincluding business description, key information and facts, and its locations andsubsidiaries.- Review of current pipeline of Immune Pharmaceuticals Ltd human therapeuticdivision.- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development,including the combination treatment modalities, across the globe.Reasons to buy- Evaluate Immune Pharmaceuticals Ltd’s strategic position with total access todetailed information on its product pipeline.- Assess the growth potential of Immune Pharmaceuticals Ltd in its therapy areas offocus.- Identify new drug targets and therapeutic classes in the Immune PharmaceuticalsLtd’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in thoseareas.- Exploit in-licensing opportunities by identifying windows of opportunity to fillportfolio gaps.
Table of Contents :List of Tables 4List of Figures 4Immune Pharmaceuticals Ltd Snapshot 5Immune Pharmaceuticals Ltd Overview 5Key Information 5Key Facts 5Immune Pharmaceuticals Ltd – Research and Development Overview 6Key Therapeutic Areas 6Immune Pharmaceuticals Ltd – Pipeline Review 8Pipeline Products by Stage of Development 8Pipeline Products – Monotherapy 9Pipeline Products – Combination Treatment Modalities 10Immune Pharmaceuticals Ltd – Pipeline Products Glance 11Immune Pharmaceuticals Ltd Clinical Stage Pipeline Products 11Phase I Products/Combination Treatment Modalities 11Immune Pharmaceuticals Ltd – Early Stage Pipeline Products 12Pre-Clinical Products/Combination Treatment Modalities 12Discovery Products/Combination Treatment Modalities 13Immune Pharmaceuticals Ltd – Drug Profiles 14Anti Ferritin Gemcitabine Paclitaxel Prodrugs 14Product Description 14…………….
Please follow link if you want More RelatedReports :Product Pipeline Review – 2012http://www.aarkstore.com/search/viewresults.asp?search=ProductPipeline Review&PubId=&pagenum=1
For More details about above & otherReports plz contact :LavanyaAarkstore.comContact: Marketing team Mob.No.918149852585Email: email@example.com ,firstname.lastname@example.orgURL: http://www.aarkstore.comhttp://in.linkedin.com/in/aarkstorehttp://www.facebook.com/aarkstore